News
Important Only
Profound Medical Corp reports results for the quarter ended June 30 - Earnings Summary
Profound Medical Corp PRN.TO reported a quarterly adjusted loss of 52 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -28 cents. The mean expectation of five analysts for the quarter was for a loss of 37 cents per share. Wall ...Reuters
Thu, Aug 14
TRADING DAY-PPI surprise clips doves' wings
By Jamie McGeever ORLANDO, Florida, Aug 14 (Reuters) - TRADING DAYMaking sense of the forces driving global marketsBy Jamie McGeever, Markets Columnist A surprise spike in U.S. producer price inflation took the wind out of stock markets' sails on Thursday and prompted investors to reasse...Reuters
Thu, Aug 14
Bolt Revenue Jumps 39 Percent in Q2
Key PointsRevenue grew 38.5% year over year (GAAP basis) in Q2 2025 and was more than double analyst expectations, with GAAP revenue of $1.80 million exceeding the analyst estimate of $0.82 million by 120.1%.Loss per share (GAAP) improved to $(4.46) in Q2 2025, beating analyst estimates for GAAP EPS...The Motley Fool
Thu, Aug 14
Jefferson Capital Revenue Up 47% in Q2
Key PointsRevenue (GAAP) surged 47.1% to $152.7 million, exceeding analyst estimates by $7.43 million.Non-GAAP EPS came in at $0.81, missing consensus non-GAAP EPS estimates of $0.83 by 2.4%.Collections rose 85.4% to $255.7 million, with U.S. growth fueled by a major one-time portfolio acquisition.T...The Motley Fool
Thu, Aug 14
Bolt Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Bolt Biotherapeutics Inc BOLT.OQ reported a quarterly adjusted loss of $4.46 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-9.20. The mean expectation of five analysts for the quarter was for a loss of $6.45 per share. Wall Stre...Reuters
Thu, Aug 14
STRZ Reports Results
Key PointsRevenue (GAAP) came in at $319.7 million, below analyst expectations.Net loss per share (GAAP) was $(2.54), significantly worse than the estimated $(0.38) per share (GAAP) and last year’s $0.26 EPS (GAAP).Subscribers declined across both U.S. and Canadian markets, with OTT and linear custo...The Motley Fool
Thu, Aug 14
Sadot Group Posts Mixed Results in Q2
Key PointsSadot Group posted its fifth consecutive quarter of positive net income, but missed analyst expectations for both revenue and earnings per share in the second quarter of 2025.Gross margin improved year over year as the company shifted focus to higher-margin specialty commodities, though ov...The Motley Fool
Thu, Aug 14
Omeros Posts 2,652 Percent Sales Jump
Key PointsOmeros (NASDAQ:OMER) posted GAAP revenue of $8.6 million for Q2 2025, far surpassing analyst expectations by roughly 2,652% (GAAP).GAAP net loss was $25.4 million for Q2 2025, showing improved cost controls and reduced interest expense versus last year.No forward financial guidance was pro...The Motley Fool
Thu, Aug 14
GT Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
GT Biopharma Inc GTBP.OQ reported a quarterly adjusted loss of 52 cents per share for the quarter ended June 30. The lone analyst forecast for the quarter was for a loss of 68 cents per share. Reported revenue was zero; analysts expected zero. GT Biopharma Inc's reported EPS for the quarter ...Reuters
Thu, Aug 14
Forte Biosciences Tops Q2 Loss Forecasts
Key PointsGAAP EPS loss of $(0.96) beat analyst expectations for Q2 2025, driven by lower general and administrative expenses.reflecting increased clinical trial activity for lead product FB102.Fortified financial position with $106.1 million in cash and cash equivalents (GAAP) as of June 30, 2025 f...The Motley Fool
Thu, Aug 14
The Metals Company Posts Q2 Net Loss
Key PointsMajor regulatory progress with U.S. authorities, advancing the pathway to commercial production for deep-sea nodule mining.Raised over $120 million in new capital during Q2 2025, significantly strengthening the balance sheet ahead of key permitting milestones.Reported a GAAP net loss of $7...The Motley Fool
Thu, Aug 14
Bionano Genomics Posts Q2 Margin Gain
Key PointsTotal revenue (GAAP) was $6.73 million for Q2 2025, down 13% year over year (GAAP), but exceeded analyst estimates by 2.6% (GAAP).Gross margin (GAAP) expanded to 52% in Q2 2025, up from 35% in Q2 2024 (non-GAAP).Operating expenses (GAAP) fell sharply by 42% to $11.3 million in Q2 2025 comp...The Motley Fool
Thu, Aug 14
ESS Tech Revenue Jumps in Fiscal Q2
Key PointsGAAP revenue grew nearly sevenfold from Q2 2024 to Q2 2025, driven by the first Energy Base battery project sales.GAAP net loss and cash burn improved significantly year over year, with GAAP operating expenses declined by 35% quarter-over-quarter.GAAP cash and cash equivalents ended the qu...The Motley Fool
Thu, Aug 14
Camp4 Reports Q2 Revenue Beats Estimates
Key PointsRevenue (GAAP) reached $1.497 million, surpassing analyst estimates and marking the company's first material recognized revenue.GAAP net loss per share narrowed to $(0.62).Cash and cash equivalents were $39.1 million, with continuing high research and development expenses.These 10 stocks c...The Motley Fool
Thu, Aug 14
Why Dogecoin Is Plummeting Today
Key PointsProducer Price Index (PPI) inflation in July was much higher than economists had anticipated. Accelerating PPI inflation could cause the Federal Reserve to take a far more cautious approach to cutting interest rates this year. The outlook on interest-rate policy is one of the most importan...The Motley Fool
Thu, Aug 14
Shimmick Revenue Jumps 42 Percent in Q2
Key PointsGAAP revenue reached $128 million for Q2 FY2025, up 42% year over year, beating expectations by $14.8 million (13.1%).Non-GAAP loss per share of $(0.14) matched estimates, narrowing sharply from last year’s loss per share, with diluted loss per share (GAAP) improving to $(0.25) from $(1.83...The Motley Fool
Thu, Aug 14
Pioneer Power Posts 147 Percent Q2 Gain
Key PointsRevenue (GAAP) climbed 147% year over year to $8.4 million in Q2 2025, surpassing GAAP expectations by 21.9%.Earnings per share (GAAP) beat estimates, with a net loss per share of $(0.12) versus the $(0.14) consensus.Strong growth in mobile electric vehicle charging drove results, but gros...The Motley Fool
Thu, Aug 14
Tvardi Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Inc TVRD.OQ reported quarterly adjusted earnings of $1.00 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-13.32. The mean expectation of seven analysts for the quarter was for a loss of 57 cents per share. Wal...Reuters
Thu, Aug 14
Pyxis Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Pyxis Oncology Inc PYXS.OQ reported a quarterly adjusted loss of 24 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -29 cents. The mean expectation of six analysts for the quarter was for a loss of 35 cents per share. Wall St...Reuters
Thu, Aug 14
Beam Global Sales Drop 52 Percent
Key Points- GAAP revenue for Q2 2025 was $7.1 million, missing analyst estimates of $7.25 million and declining 52.0% from Q2 2024.- Gross margin improved to 20% on a GAAP basis and 30% on a non-GAAP basis, reflecting stronger operational controls and cost cuts.- Commercial and international sales n...The Motley Fool
Thu, Aug 14
